Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  International Journal of Molecular Medicine

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijmm.2015.2383PMID 26497016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty of 1000 evaluation for Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control.

  2017cited by this paper
• Growth inhibition and induction of apoptosis in SGC‑7901 human gastric cancer cells by evodiamine.

  2014influential reference
• An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control

  2014cited by this paper
• Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells

  2014cited by this paper
• Roles of Wnt/β-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment

  2014cited by this paper
• Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein

  2014cited by this paper
• Activation of JNK Contributes to Evodiamine-Induced Apoptosis and G2/M Arrest in Human Colorectal Carcinoma Cells: A Structure-Activity Study of Evodiamine

  2014cited by this paper
• Integrative ChIP-seq/Microarray Analysis Identifies a CTNNB1 Target Signature Enriched in Intestinal Stem Cells and Colon Cancer

  2014cited by this paper
• Downregulation of GSK3β by miR-544a to maintain self-renewal ability of lung caner stem cells

  2014cited by this paper
• Evodiamine might inhibit TGF‐beta1‐induced epithelial–mesenchymal transition in NRK52E cells via Smad and PPAR‐gamma pathway

  2014cited by this paper
• JMJD2B Promotes Epithelial–Mesenchymal Transition by Cooperating with β-Catenin and Enhances Gastric Cancer Metastasis

  2013cited by this paper
• Gastric cancer stem cells: therapeutic targets

  2013cited by this paper
• Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma

  2013cited by this paper
• Gastric cancer stem cells: a novel therapeutic target.

  2013cited by this paper
• The Role of Epithelial Mesenchymal Transition Markers in Thyroid Carcinoma Progression

  2013cited by this paper
• Gastric stem cells and gastric cancer stem cells

  2013cited by this paper
• Wnt Signaling and the Control of Human Stem Cell Fate

  2013cited by this paper
• Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy.

  2012influential reference
• Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.

  2012cited by this paper
• Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression

  2012cited by this paper
• The Wnt/β-catenin pathway regulates self-renewal of cancer stem-like cells in human gastric cancer.

  2012cited by this paper
• Cancer stem cells: current status and evolving complexities.

  2012cited by this paper
• Gastric cancer stem-like cells possess higher capability of invasion and metastasis in association with a mesenchymal transition phenotype.

  2011cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

  2010cited by this paper
• [Therapeutic targets].

  2009cited by this paper
• Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44

  2009cited by this paper
• Gastric cancer

  2009cited by this paper
• Gastric cancer – Authors' reply

  2009cited by this paper
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• The epithelial–mesenchymal transition: new insights in signaling, development, and disease

  2006cited by this paper
• The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer

  2005cited by this paper
• The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer.

  2005cited by this paper
• The Nociceptive and Anti-Nociceptive Effects of Evodiamine from Fruits of Evodia rutaecarpa in Mice

  2003cited by this paper
• [Gastric cancer].

  1996cited by this paper

• Oncopreventive and Oncotherapeutic Potential of Plant Secondary Metabolites Against Gastric Cancer: A Review

  2026cites this paper
• Wnt signaling pathway: Therapeutic target of natural products for cancer therapy.

  2026cites this paper
• Harnessing Natural Products to Surmount Drug Resistance in Gastric Cancer: Mechanisms and Therapeutic Perspectives

  2025influential citation
• Tumor Microenvironment-Activated and ROS-Augmented Nanoplatform Amplified PDT against Colorectal Cancer through Impairing GPX4 To Induce Ferroptosis.

  2025cites this paper
• Evodiamine Inhibits Colorectal Cancer by Downregulating ASS1 via Wnt/β-Catenin/c-MYC Pathway to Block Arginine Synthesis

  2025cites this paper
• Mechanisms of neuroendocrine differentiation in castration-resistant prostate cancer and advances in the treatment of neuroendocrine prostate cancer

  2025cites this paper
• Decoding the role of cancer stem cells in digestive tract tumors: Mechanisms and therapeutic implications (Review)

  2025cites this paper
• Advances in Gastric Cancer Management: Signaling Pathways, Emerging Diagnostic and Therapeutic Strategies.

  2025cites this paper
• Progress on the effects and underlying mechanisms of evodiamine in digestive system diseases, and its toxicity: A systematic review and meta-analysis.

  2024cites this paper
• Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa

  2024cites this paper
• Exploiting Transcription Factors to Target EMT and Cancer Stem Cells for Tumor Modulation and Therapy.

  2024cites this paper
• Targeting YAP1 to improve the efficacy of immune checkpoint inhibitors in liver cancer: mechanism and strategy

  2024cites this paper
• Deciphering drug resistance in gastric cancer: Potential mechanisms and future perspectives.

  2024cites this paper
• The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy

  2024cites this paper
• Targeting the key players of phenotypic plasticity in cancer cells by phytochemicals

  2024cites this paper
• Research Progress on the Mechanism of Evodiamine against Hepatocarcinoma

  2023cites this paper
• Research Progress on the Anti-Tumor Mechanism and Reversal of Multidrug Resistance of Zuojin Pill and its Main Components, Evodiamine and Berberine

  2023influential citation
• Development of a new drug candidate for the inhibition of Lassa virus glycoprotein and nucleoprotein by modification of evodiamine as promising therapeutic agents

  2023cites this paper
• Traditional Chinese medicine Euodiae Fructus: botany, traditional use, phytochemistry, pharmacology, toxicity and quality control

  2023cites this paper
• Gastric cancer and mesenchymal stem cell-derived exosomes: from pro-tumorigenic effects to anti-cancer vehicles

  2023cites this paper
• Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics

  2023cites this paper
• BRG1 enhances porcine iPSC pluripotency through WNT/β-catenin and autophagy pathways.

  2023cites this paper
• The signaling pathways and targets of natural products from traditional Chinese medicine treating gastric cancer provide new candidate therapeutic strategies.

  2023cites this paper
• Major Indole Alkaloids in Evodia Rutaecarpa: The Latest Insights and Review of Their Impact on Gastrointestinal Diseases.

  2023cites this paper
• Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-κB Signaling Pathway

  2022cites this paper
• Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.

  2022cites this paper
• Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers

  2022cites this paper
• Induction of Apoptosis and Effect on the FAK/AKT/mTOR Signal Pathway by Evodiamine in Gastric Cancer Cells

  2022cites this paper
• Evodiamine inhibits stemness and metastasis by altering the SOX9–β‐catenin axis in non‐small‐cell lung cancer

  2022cites this paper
• Targeting Gastric Cancer Stem Cells to Enhance Treatment Response

  2022cites this paper
• Potential of Bioactive Food Components against Gastric Cancer: Insights into Molecular Mechanism and Therapeutic Targets

  2021cites this paper
• Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70

  2021cites this paper
• The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment

  2021cites this paper
• A bioinformatics analysis to evaluate the prognostic value of stemness-related genes in gastric cancer

  2021cites this paper
• Phytomedicines Targeting Cancer Stem Cells: Therapeutic Opportunities and Prospects for Pharmaceutical Development

  2021cites this paper
• Evodiamine Relieve LPS-Induced Mastitis by Inhibiting AKT/NF-κB p65 and MAPK Signaling Pathways

  2021cites this paper
• Emerging Potential of Naturally Occurring Molecules against Gastric Cancer: Insights Molecular Mechanism and Therapeutic Targets

  2021cites this paper
• Research progress on evodiamine, a bioactive alkaloid of Evodiae fructus: Focus on its anti-cancer activity and bioavailability (Review).

  2021cites this paper
• Evodiamine Inhibits Gastric Cancer Cell Proliferation via PTEN-Mediated EGF/PI3K Signaling Pathway

  2021cites this paper
• Evodiamine: A review of its pharmacology, toxicity, pharmacokinetics and preparation researches.

  2020cites this paper
• Pancreatic cancer stem cells mediate drug resistance against evodiamine by activation of HIF-1α-Notch-Hes1/5 pathway

  2020cites this paper
• Potential Applications of Capsaicinoids in Small Cell Lung Cancer Therapy

  2019cites this paper
• Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial-mesenchymal transition

  2019cites this paper
• Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects

  2019cites this paper
• A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells

  2018cites this paper
• Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial–Mesenchymal Transition of Thyroid Carcinoma Cells

  2018cites this paper
• Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives

  2018cites this paper
• Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.

  2018cites this paper
• Re-Purposing Evodiamine as an Anti-CancerDrug: Effects on Migration and Apoptosis

  2018cites this paper
• Notch signaling molecule is involved in the invasion of MiaPaCa2 cells induced by CoCl2 via regulating epithelial-mesenchymal transition

  2018cites this paper
• Antiproliferative hydrogen sulfide releasing evodiamine derivatives and their apoptosis inducing properties.

  2018cites this paper
• Anticancer Activity of Natural and Synthetic Capsaicin Analogs

  2018cites this paper
• FOXO1 reduces tumorsphere formation capacity via reciprocal down-regulation of LGR5 in gastric cancer cells

  2018cites this paper
• Advances in cancer stem cell targeting: How to strike the evil at its root

  2017cites this paper
• ESMO Translational Research Fellowship - Sarah Kammerer

  2017cites this paper
• Targeting Cancer Stem Cells with Small Molecules

  2017cites this paper
• The self-renewal signaling pathways utilized by gastric cancer stem cells

  2017cites this paper
• Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway

  2017cites this paper
• Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway

  2017cites this paper
• Evodiamine Prevents Isoproterenol-Induced Cardiac Fibrosis by Regulating Endothelial-to-Mesenchymal Transition

  2016cites this paper
• Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine.

  2016cites this paper
• Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

  2016cites this paper
• Evodiamine and Its Role in Chronic Diseases.

  2016cites this paper
• Drug Discovery from Mother Nature

  2016cites this paper
• Screening and identification of hepatotoxic component in Evodia rutaecarpa based on spectrum-effect relationship and UPLC-Q-TOFMS.

  2016cites this paper
• Evodiamine Attenuates PDGF-BB-Induced Migration of Rat Vascular Smooth Muscle Cells through Activating PPARγ

  2015cites this paper